{
  "status": "success",
  "requires_generation": true,
  "session_id": "69120342-8cb2-4bd8-b339-ca01d1f62962",
  "pd_log_s3_link": "s3://study-risk-assessment/site_pd_logs/Flourish Research - Philadelphia.json",
  "section_mappings": {
    "protocol": {
      "primary_objective": [
        10
      ],
      "primary_and_secondary_endpoints": [
        10
      ],
      "study_design": [
        11
      ],
      "schedule_of_assessments": [
        14,
        15,
        16,
        17,
        18,
        19,
        20
      ],
      "study_population": [
        31
      ],
      "inclusion_exclusion_criteria": [
        31,
        32,
        33,
        34,
        35,
        36,
        37
      ],
      "treatment_dosing_and_assessments": [
        38,
        39
      ],
      "safety_monitoring_and_reporting": [
        54,
        55,
        56,
        57,
        58,
        59
      ],
      "key_safety_concerns": [
        23
      ],
      "data_management_and_edc": [
        70
      ],
      "regulatory_and_ethics": [
        65,
        66,
        67
      ],
      "imaging_biomarkers_and_lab_procedures": [
        50,
        51,
        52,
        53
      ],
      "critical_to_quality_factors": []
    }
  },
  "message": "Files processed successfully",
  "hashes": {
    "protocol_doc_hash": "523e9c1e0b48308899376530ea93283932a58de902a00ba6901ef30d5b9fb740",
    "pd_log_hash": "54dcedeb5660576a211c7c0f8b0a89f13e1eb25b4d850c36063c12f916e34f7b",
    "lab_manual_hash": "",
    "pharma_manual_hash": ""
  }
}